Peter A Thompson Insider Trading $PMVP PMV Pharmaceuticals, Inc.
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).
Peter A Thompson in PMV Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 475,000 shares
Latest Transaction: Sep 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A Thompson in PMV Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 114,039 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 380,133 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 518,191 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,076,891 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 4,025,076 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 114,039 | 0 | 114,039 | 0 to 114 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 380,133 | 0 | 6,475,291 | 6.1 M to 6.5 M (+6.24 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 518,191 | 0 | 6,095,158 | 5.6 M to 6.1 M (+9.29 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 1,076,891 | 0 | 5,576,967 | 4.5 M to 5.6 M (+23.93 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 4,025,076 | 0 | 4,500,076 | 475 K to 4.5 M (+847.38 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
Page: 1